HOME › DRUGS › EFALIZUMAB
ACTIVE SUBSTANCE / INN

EFALIZUMAB

Brand name(s): Raptiva
EMA LISTED
WITHDRAWN
Psoriasis
ACTIVE SUBSTANCE
Efalizumab
REGULATORS
EMA
SPONSORS / MAH
Serono Europe Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RaptivaSerono Europe LimitedWithdrawn20/09/2004Psoriasis

FULL INTELLIGENCE ON EFALIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →